Found 20 matching trials
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV
PHASE1Study objectives: To evaluate the immunogenicity and immunity persistence a...
Location
Zhejiang Provincial Center for Disease Control and Prevention
Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
NAPopular title: Clinical study of Omicron BA.4/5-Delta strain recombinant no...
Location
Multiple Locations
To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2
NAAn open experimental design was used in this study, and 240 subjects were p...
Location
Hunan Provincial Center for Disease Control and Prevention
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac
PHASE1Study objectives: To evaluate the immunogenicity and immunity persistence a...
Location
Zhejiang Provincial Center for Disease Control and Prevention
ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization
PHASE1The purpose of this study is to evaluate the immunogenicity and safety of t...
Location
Hunan Provincial Center for Disease Control and Prevention
Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity
NAPopular topic: Clinical study on immunogenicity and safety evaluation of se...
Location
Hunan Provincial Center for Disease Control and Prevention
Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell)
PHASE3Popular topic:Clinical study on the immune program of recombinant Novel Cor...
Location
Hunan Center for Disease Control and Prevention
Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
PHASE3Popular topic:Clinical trials of the consistency and non-inferiority bridgi...
Location
Hunan Provincial Center for Disease Control and Prevention
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
PHASE3A randomized, double-blind, placebo-controlled international multicenter cl...
Location
Hunan Provincial Center for Disease Control and Prevention
A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)
PHASE3The study was designed as a randomized, blind and controlled trial. A total...
Location
Uzbekistan, Tashkent city, Said baraka street 10